Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,101.9
9.8 (0.32%)

 

  • STI Straits Times Index
    3,101.9
    9.8 (0.32%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,501.7
    4.8 (0.32%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,766.7
    -22.2 (-0.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,607.4
    33.6 (0.94%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 818.5M
  • Value: 1,115.1M
  • Rise: 182
  • Fall: 131
  • Unch: 448

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.083-
Genting Sing0.760+0.015
SingHaiyi0.117-
CapLand IntCom T2.060-0.010
Singtel2.380-
Metal Component0.047-0.003
HGH0.019-
Golden Agri-Res0.235+0.010
HPH Trust USD0.230+0.005
Mapletree Log Tr1.870-

World Indices

World Indices
Name Last Change
Nasdaq 15,537.7 -245.1
HSI 23,766.7 -22.2
HSCEI 8,455.5 -50.9
Jakarta 6,538.5 -45.3
Nikkei 225 27,935.6
SSE Comp 3,607.4 +33.6
Shanghai A 3,781.0 +35.2
Shanghai B 286.0 +2.9
KOSPI 2,968.3 +23.1

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SDI LTD SDI
Updated on 03 Dec 2021 (End of trading day)
Last (AUD): 1.055 Change: -0.005 High: 1.100 Remarks: -
Change (%): -0.47 Low: 1.055

Company Background

SDI Ltd. engages in the research, development, manufacturing, and marketing of dental restorative products, tooth whitening systems, and small dental equipment for sale to dental distributors, dental dealers and dentists worldwide. The firm operates through the following segments: SDI Australia; SDI Europe; SDI USA; and SDI Brazil. Its products include alloys, adhesives, sealants, cements, equipment, Riva Star tooth desensitizing agent and cavity cleanser, etchants, glass lonomers, composites, tooth whitening, and accessories. The company was founded by Jeffery James Cheetham and Pamela Joy Cheetham in 1972 and is headquartered in Melbourne, Australia.

Click to show Stock Prices chart

Key Statistics

EPS (AUD) a 0.07522 Trailing EPS (AUD) b 0.07522 NAV (AUD) c 0.6712
PE a 14.026 Trailing PE d 14.026 Price / NAV c 1.5718
Dividend Yield (%) e 2.986 Cash In Hand (AUD) f 0.0888 Issued & Paid-up Shares g 118,866,000
Piotroski F Score 6 Market Cap (M) 125.404 Free Float (%) 37.1
Return on Equity (ROE) (%) h 11.207 Revenue Growth (%) TTM i 21.185
Net Earnings Growth (%) j 111.022 Net Debt/Equity k Net Cash
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 30 Jul 2015. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.035
-3.21 %
10 Days --0.015
-1.40 %
20 Days -+0.040
+3.94 %
Medium Term Return 3 Months 0.017-0.015
+0.19 %
6 Months 0.017+0.145
+17.80 %
1 Year 0.032+0.235
+32.56 %
Long Term Return 2 Years 0.050+0.195
+28.49 %
3 Years 0.087+0.460
+91.93 %
5 Years 0.135+0.360
+71.22 %
Annualised Return Annualised --
+11.36 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SDI LTD ASX 125.404 14.026 14.026 1.5718 2.986
Industry Medical Specialties ASX 2,134.509 67.622 64.976 8.9783 0.856
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 17,774.698 36.313 36.429 11.6997 1.353
Local Peer COCHLEAR LTD ASX 13,900.910 42.576 42.576 8.1688 1.206
Local Peer EBOS GROUP ASX 5,697.289 30.747 30.747 4.0377 2.478
Local Peer NANOSONICS LIMITED ASX 1,614.191 188.181 188.178 11.9074 -
Local Peer INCANNEX HEALTHCARE LTD ASX 640.521 - - 74.6479 -
Local Peer METRICS INCOME OPPORTUNITIES TRUST ASX 611.873 - - -428.5714 -
Local Peer AROA BIOSURGERY LTD ASX 379.468 - - 3.8771 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 352.836 - - 5.1659 -
Local Peer IMPEDIMED LIMITED ASX 293.009 - - 11.4583 -
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 272.718 - - 4.3821 -
Local Peer CLARITY PHARMACEUTICALS LTD ASX 225.397 - - 11.1111 -
Local Peer EMVISION MEDICAL DEVICES LTD ASX 197.776 - - 19.6769 -
Other Local Peers SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), MICRO-X LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), OPTISCAN IMAGING (ASX), CLEANSPACE HOLDINGS LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), DIMERIX LTD (ASX), COMPUMEDICS (ASX), CARDIEX LTD (ASX), RESONANCE HEALTH LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), RESPIRI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), TRUSCREEN GROUP LTD (ASX), ADHERIUM LIMITED (ASX), OVENTUS MEDICAL LTD (ASX), USCOM LTD (ASX), METALICITY LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), ANALYTICA (ASX)
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 250,657.873 39.319 29.265 6.4753 0.139
Global Peer ABBOTT LABORATORIES NYSE 230,355.138 51.499 31.941 6.6921 1.176
Global Peer DANAHER CORP NYSE 223,619.726 63.709 39.081 5.5650 0.229
Global Peer MEDTRONIC PLC NYSE 143,725.188 39.857 30.547 2.7644 2.265
Global Peer INTUITIVE SURGICAL INC NASDAQ 114,812.904 108.253 67.969 10.0617 -
Global Peer STRYKER CORP NYSE 93,129.239 58.242 49.015 6.5686 0.951
Global Peer BECTON DICKINSON & CO NYSE 69,335.939 34.633 34.633 2.9287 1.379
Global Peer EDWARDS LIFESCIENCES CORP NYSE 67,727.752 82.253 45.846 12.2224 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 56,230.105 - 53.964 3.4157 -
Global Peer DEXCOM INC NASDAQ 50,350.010 102.006 95.126 23.5710 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), PERKINELMER INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), WATERS CORP (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), MASIMO CORPORATION (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), TELEFLEX INC (NYSE), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), NOVOCURE LTD (NASDAQ), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), ANGELALIGN TECHNOLOGY INC (HKEx), MICROPORT SCIENTIFIC CORPORATION (HKEx), GLOBUS MED INC (NYSE), SHANGHAI MICROPORT MEDBOT (GROUP) C (HKEx), SHANDONG WEIGAO GROUP MEDICAL (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), STEVANATO GROUP S.P.A. (NYSE), QUIDEL CORP (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INMODE LTD (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NEVRO CORP (NYSE), ATRICURE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), HAEMONETICS CORP (NYSE), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), CAREDX INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), OUTSET MEDICAL INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH (HANGZHOU) INC (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), CUE HEALTH INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PARAGON 28 INC (NYSE), SILK ROAD MEDICAL INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), VICARIOUS SURGICAL INC (NYSE), AVANOS MEDICAL INC (NYSE), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), INOVIO PHARMACEUTICALS INC (NASDAQ), PEIJIA MEDICAL LIMITED (HKEx), ATRION CORP (NASDAQ), KANGJI MEDICAL HLDGS LTD (HKEx), CERUS CORP (NASDAQ), BUTTERFLY NETWORK INC (NYSE), ORTHOPEDIATRICS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), PULMONX CORPORATION (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), ALPHATEC HLDGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SUPERMX (Bursa), ANGIODYNAMICS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), BIOVENTUS INC (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), CHINA ISOTOPE & RADIATION CORP (HKEx), VIEWRAY INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), NATUS MEDICAL INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), INTERCURE LTD (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), INOGEN INC (NASDAQ), 908 DEVICES INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), SEMLER SCIENTIFIC INC (NASDAQ), SI BONE INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SISRAM MEDICAL LTD (HKEx), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAPOTHERM INC (NYSE), AIRSCULPT TECHNOLOGIES INC (NASDAQ), IRADIMED CORP (NASDAQ), DERMTECH INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYXOAH SA (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), APYX MEDICAL CORPORATION (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), STEREOTAXIS INC (NYSE American), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), AXOGEN INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), FLUIDIGM CORP DEL (NASDAQ), AVITA MEDICAL INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), CLEARPOINT NEURO INC (NASDAQ), PAVMED INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), LUCIRA HEALTH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), DARIOHEALTH CORP (NASDAQ), NEUROPACE INC (NASDAQ), QUOTIENT LTD (NASDAQ), CVRX INC (NASDAQ), SIENTRA INC (NASDAQ), SONENDO INC (NYSE), PROFOUND MED CORP (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), ONCOCYTE CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), EARGO INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), TELA BIO INC (NASDAQ), MINERVA SURGICAL INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), CONFORMIS INC (NASDAQ), UGHealthcare (SGX), Medtecs Intl (SGX), INTRICOM CORP (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), FONAR CORP (NASDAQ), NEURONETICS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), ELECTROMED INC (NYSE American), CRYO-CELL INTERNATIONAL INC (NASDAQ), RGTBHD (Bursa), BIOSIG TECHNOLOGIES INC (NASDAQ), IRIDEX CORP (NASDAQ), KELFRED HOLDINGS LTD (HKEx), ALPHA PRO TECH (NYSE American), INVACARE CORP (NYSE), ACUTUS MEDICAL INC (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), VOLITIONRX LIMITED (NYSE American), REWALK ROBOTICS LTD (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), LENSAR INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), NEPHROS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CELSION CORPORATION (NASDAQ), ENVVENO MED CORP (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), AVINGER INC (NASDAQ), ELECTROCORE INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), NUTRIBAND INC (NASDAQ), ADVENTA (Bursa), YUNNAN ENERGY INTL CO LTD (HKEx), NEUROMETRIX INC (NASDAQ), NEOVASC INC (NASDAQ), APPLIED UV INC (NASDAQ), DAXOR CORP (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), TIVIC HEALTH SYSTEMS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), AETHLON MEDICAL INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), Yunnan Energy (SGX), Biolidics (SGX), HEARTBEAM INC (NASDAQ), BLUEJAY DIAGNOSTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), INSPIREMD INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), MOTUS GI HOLDINGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), DYNATRONICS CORP (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), XTANT MEDICAL HLDGS INC (NYSE American), RA MEDICAL SYSTEMS INC (NYSE American), LKL (Bursa), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.